Cryo-Cell International Inc (CCEL) stock
CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
$4.63+0.08 (+1.76%)
Close on Nov 17, 2026Market cap $37.33MP/E –Yield –
Cryo-Cell International net income
Net income is the profit left for shareholders after every expense, interest and tax.
Cryo-Cell International's net income for the twelve months ending Aug 31, 2026 was -$1.95M. For fiscal 2025 it was -$2.43M, down 704.2% from the year before. The highest annual figure on record is $8.11M in fiscal 2015.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | -$2.43M | -704.2% |
| FY2024 | Nov 30, 2024 | $402.10K | – |
| FY2023 | Nov 30, 2023 | -$9.52M | -443.6% |
| FY2022 | Nov 30, 2022 | $2.77M | +33.0% |
| FY2021 | Nov 30, 2021 | $2.08M | -42.5% |
| FY2020 | Nov 30, 2020 | $3.62M | +58.2% |
| FY2019 | Nov 30, 2019 | $2.29M | – |
| FY2018 | Nov 30, 2018 | -$854.82K | -136.9% |
| FY2017 | Nov 30, 2017 | $2.32M | – |
| FY2016 | Nov 30, 2016 | -$1.32M | -116.3% |
| FY2015 | Nov 30, 2015 | $8.11M | +1364.2% |
| FY2014 | Nov 30, 2014 | $553.62K | +1917.9% |
| FY2013 | Nov 30, 2013 | $27.44K | – |
| FY2012 | Nov 30, 2012 | -$6.31M | – |
| FY2011 | Nov 30, 2011 | -$2.10M | -160.5% |
| FY2010 | Nov 30, 2010 | $3.46M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | $1.27M | +69.5% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $554.59K | +55.9% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $47.11K | -83.3% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | -$3.82M | – |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $749.41K | -28.7% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $355.79K | -45.7% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $282.86K | -49.1% |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | -$1.86M | – |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $1.05M | +54.5% |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $655.79K | +196.8% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | $556.24K | -27.5% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | -$11.19M | -1435.6% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | $680.56K | +45.8% |
| Q2 FY2023CQ2 2023 | May 31, 2023 | $220.98K | -65.2% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | $766.81K | -7.8% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | $837.82K | – |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | $466.82K | -45.5% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | $634.72K | -45.8% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | $832.05K | +20.0% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | -$637.19K | -153.1% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | $856.49K | +9.2% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | $1.17M | +22.8% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | $693.59K | +1.0% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | $1.20M | +42.0% |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | $784.47K | -29.7% |
| Q2 FY2020CQ2 2020 | May 31, 2020 | $953.34K | +1676.2% |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | $686.97K | +149.0% |
| Q4 FY2019CQ4 2019 | Nov 30, 2019 | $844.97K | -5.1% |
| Q3 FY2019CQ3 2019 | Aug 31, 2019 | $1.12M | +355.6% |
| Q2 FY2019CQ2 2019 | May 31, 2019 | $53.67K | -90.1% |
| Q1 FY2019CQ1 2019 | Feb 28, 2019 | $275.88K | – |
| Q4 FY2018CQ4 2018 | Nov 30, 2018 | $890.76K | +31.1% |
| Q3 FY2018CQ3 2018 | Aug 31, 2018 | $244.98K | -62.4% |
| Q2 FY2018CQ2 2018 | May 31, 2018 | $539.51K | +8.6% |
| Q1 FY2018CQ1 2018 | Feb 28, 2018 | -$2.53M | -619.6% |
| Q4 FY2017CQ4 2017 | Nov 30, 2017 | $679.22K | -16.1% |
| Q3 FY2017CQ3 2017 | Aug 31, 2017 | $652.02K | – |
| Q2 FY2017CQ2 2017 | May 31, 2017 | $496.94K | – |
| Q1 FY2017CQ1 2017 | Feb 28, 2017 | $486.92K | – |
| Q4 FY2016CQ4 2016 | Nov 30, 2016 | $809.37K | – |
See a number that looks wrong?